Advertisement

Topics

Human medicines European public assessment report (EPAR): Apealea, paclitaxel, Ovarian Neoplasms, Date of authorisation: 20/11/2018, Revision: 1, Status: Authorised

10:00 EDT 10 May 2019 | European Medicines Agency

Human medicines European public assessment report (EPAR): Apealea, paclitaxel, Ovarian Neoplasms, Date of authorisation: 20/11/2018, Revision: 1, Status: Authorised

Original Article: Human medicines European public assessment report (EPAR): Apealea, paclitaxel, Ovarian Neoplasms, Date of authorisation: 20/11/2018, Revision: 1, Status: Authorised

NEXT ARTICLE

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Apealea, paclitaxel, Ovarian Neoplasms, Date of authorisation: 20/11/2018, Revision: 1, Status: Authorised"

Advertisement
Quick Search
Advertisement
Advertisement